The Concept

IMAPAC will be hosting a series of webinars from February 2023 to April 2023 in the lead up to our main conference, 10th Annual Biologics Manufacturing Asia in Singapore. These webinars will cover timely topics facing the APAC biologics manufacturing industry, and will set the stage for more in-depth discussion this coming March during the main conference.

APAC Bioprocessing Festival 2023 aims to bring together 4-5 expertises in the Biologics manufacturing sector and solution providers across the biologics development & manufacturing lifecycle into a panel discussion, to find solutions and to maximize the value of new therapies.

Connect with the attendees of Biologics Manufacturing Asia (BMA) 2023 before or after the conference. The biopharma/big pharma decision makers and Key Opinion Leaders (KOLs) will be targeted and engaged with your customised webinar highlighting your solutions and technologies.

Festival Details Brochure
Biologics Pipelines
Manufacturing Facilities
Webcast Series Topics and Agenda

12th April 2023

Session Title: SMART Manufacturing- Bioprocessing 4.0

Date: 12th April 2023, Wednesday

Time: TBA

22nd February 2023

Session Title: Challenges and Successes of Biologics Continuous Manufacturing

Date: 22nd February 2023, Wednesday
Time: TBA

1st March 2023

Session Title: Recent Advances, Trends and Future Directions in Downstream Manufacturing

Date: 22nd February 2023, Wednesday
Time: TBA

8th March 2023

Session Title: Biologics Drug Product Anlaysis & QC

Date: 8th March 2023, Wednesday

Time: TBA

22nd March 2023

Session Title: Emerging BioTherapies & Novel Therapeutics Modalities: Development, Manufacturing, Quality and Regulatory Acceptance

Date: 29th March 2023, Wednesday

Time: TBA

5th April 2023

Session Title: Application of Data Analytics into Biomanufacturing

Date: 5th April 2023, Wednesday

Time: TBA

Sponsorship Opportunities
left quote

Great conference organization and relevant topics on Biologics Manufacturing and Bioprocessing trends

Chief Medical Officer, GenSight Biologics, France